Skip to content
HowShorted

Avalo Therapeutics, Inc. short interest in 2019

In 2019, Avalo Therapeutics, Inc.'s disclosed short interest ran from 1.69% of shares outstanding on 15 Oct 2019 to 1.26% on 31 Dec 2019, a change of -0.43 percentage points. The year's high was 2.04% on 31 Oct 2019 and its low 1.26% on 31 Dec 2019, averaging 1.63% across 6 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 22.38 days on 31 Oct 2019. Full history: Avalo Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Avalo Therapeutics, Inc. in 2019

2019 in figures

Start of year
1.69% (15 Oct 2019)
End of year
1.26% (31 Dec 2019)
Change
-0.43 pp
High
2.04% (31 Oct 2019)
Low
1.26% (31 Dec 2019)
Average
1.63%
Highest days to cover
22.38 (31 Oct 2019)
SEC filings marked
8

Every report in 2019

Avalo Therapeutics, Inc. short interest in 2019
SettlementShort interestDays to coverFilings since previous
15 Oct 20191.69%19.2910-K filed, results (8-K), 10-Q filed, results (8-K), 10-Q filed, results (8-K)
31 Oct 20192.04%22.38
15 Nov 20191.87%19.0810-Q filed, results (8-K)
29 Nov 20191.53%8.54
13 Dec 20191.36%7.84
31 Dec 20191.26%2.98

See also: Avalo Therapeutics, Inc.'s full history · most shorted US stocks of 2019 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.